SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-5.4%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$3.27B
AUM Growth
+$3.27B
(-37%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-45.92%
Top 10 Holdings %
Top 10 Hldgs %
36.77%
Holding
111
New
16
Increased
19
Reduced
19
Closed
23
Top Buys
| 1 |
Centene
CNC
|
$101M |
| 2 |
Visa
V
|
$97.1M |
| 3 |
Las Vegas Sands
LVS
|
$88.4M |
| 4 |
S&P Global
SPGI
|
$84.8M |
| 5 |
Charles Schwab
SCHW
|
$82.9M |
Top Sells
| 1 |
Adobe
ADBE
|
$222M |
| 2 |
Amazon
AMZN
|
$205M |
| 3 |
Analog Devices
ADI
|
$144M |
| 4 |
Quanta Services
PWR
|
$133M |
| 5 |
Cencora
COR
|
$133M |
Sector Composition
| 1 | Healthcare | 47.04% |
| 2 | Consumer Discretionary | 18.58% |
| 3 | Financials | 10.68% |
| 4 | Industrials | 10.44% |
| 5 | Technology | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $184M | 5.61% | 595,747 -269,253 | -31% | -$83M |
|
2
Union Pacific
UNP
$133B
| $168M | 5.12% | 613,628 -194,392 | -24% | -$53.1M |
|
|
3
Amazon
AMZN
$2.44T
| $147M | 4.49% | 45,122 -62,908 | -58% | -$205M |
|
4
UnitedHealth
UNH
$281B
| $123M | 3.75% | 240,997 -215,793 | -47% | -$110M |
|
5
Estee Lauder
EL
$33B
| $101M | 3.1% | 372,475 -76,885 | -17% | -$20.9M |
|
|
6
Centene
CNC
$14.3B
| $101M | 3.08% | +1,197,206 | New | +$101M |
|
7
Otis Worldwide
OTIS
$33.9B
| $99.8M | 3.05% | 1,297,480 -1,187,100 | -48% | -$91.3M |
|
|
8
Visa
V
$683B
| $97.1M | 2.97% | +437,990 | New | +$97.1M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $93.7M | 2.86% | 1,531,923 +279,977 | +22% | +$17.1M |
|
10
IQVIA
IQV
$32.4B
| $89.4M | 2.73% | 386,710 -173,050 | -31% | -$40M |
|
|
11
Las Vegas Sands
LVS
$39.6B
| $88.4M | 2.7% | +2,275,282 | New | +$88.4M |
|
12
Tapestry
TPR
$21.2B
| $86.2M | 2.63% | 2,320,100 -2,227,360 | -49% | -$82.7M |
|
|
13
S&P Global
SPGI
$167B
| $84.8M | 2.59% | +206,760 | New | +$84.8M |
|
|
14
Charles Schwab
SCHW
$174B
| $82.9M | 2.53% | +982,790 | New | +$82.9M |
|
15
Humana
HUM
$36.5B
| $82.2M | 2.51% | +188,888 | New | +$82.2M |
|
16
Royalty Pharma
RPRX
$15.6B
| $78.9M | 2.41% | 2,025,610 +58,337 | +3% | +$2.27M |
|
17
GFL Environmental
GFL
$18.2B
| $74.3M | 2.27% | 2,284,496 -2,342,544 | -51% | -$76.2M |
|
18
Johnson & Johnson
JNJ
$427B
| $73.6M | 2.25% | +415,310 | New | +$73.6M |
|
19
Mastercard
MA
$538B
| $68.2M | 2.08% | 190,943 -59,327 | -24% | -$21.2M |
|
20
Danaher
DHR
$147B
| $68.2M | 2.08% | 232,570 +12,370 | +6% | +$3.63M |
|
21
Thermo Fisher Scientific
TMO
$186B
| $68M | 2.08% | 115,069 -155,401 | -57% | -$91.8M |
|
22
Kura Oncology
KURA
$686M
| $62.6M | 1.91% | 3,893,019 +320,600 | +9% | +$5.16M |
|
23
Fulcrum Therapeutics
FULC
$351M
| $61.8M | 1.89% | 2,613,412 +237,841 | +10% | +$5.62M |
|
24
RH
RH
$4.23B
| $59.3M | 1.81% | 181,835 -68,085 | -27% | -$22.2M |
|
|
25
Cencora
COR
$56.5B
| $59.3M | 1.81% | 383,138 -860,672 | -69% | -$133M |
|